论文部分内容阅读
春季结角膜炎为一种外源性多因素引起的与Ⅰ型变态反应有关的过敏性疾病。从前用皮质激素治疗取得相当疗效,但久用会产生副作用如出现青光眼、白内障、继发感染等。近年来已研制出一种有效的抗过敏药色甘酸钠(DSCG),它能抑制致敏的肥大细胞脱颗粒释放组织胺等介质,达到治疗目的。今将1983年门诊所见的春季结角膜炎病人,用2％色甘酸钠异构体治疗结果报告如下:接受治疗的共98例,男77例、女21例;194眼,有两例为单眼、轻度的首次发病,病程只一周,余均为双眼发病。首次发病的年龄最小的8个月,最大的45岁,以5～19岁年
Spring conjunctivitis is an exogenous multi-factorial allergic disease associated with type I allergy. In the past with corticosteroid treatment has achieved considerable efficacy, but for a long time there will be side effects such as glaucoma, cataracts, secondary infection. In recent years, it has developed an effective allergy medicine cromolyn (DSCG), which can inhibit the sensitized mast cells degranulation release histamine and other media for therapeutic purposes. The 1983 spring knot conjunctivitis patients, with 2% cromolyn isomer treatment results reported as follows: a total of 98 cases were treated, 77 males and 21 females; 194 eyes, there are two cases of Monocular, mild first onset, the course of only one week, I are more than two eyes. The youngest onset of the first 8 months, the largest 45-year-old, aged 5 to 19 years